SEC Form 4 · accession 0001093557-17-000145
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Alexander Collins
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 8:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 1, 2017 | A | 1,002 | $0.001 | A | 1,502 | D | |
| Common StockF1,F2 | Jun 1, 2017 | A | 4,353 | $0.001 | A | 5,855 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- F2Included in this number are 5,355 unvested restricted stock units which were granted on June 1, 2017 and shall vest on June 1, 2018.